104 related articles for article (PubMed ID: 36945083)
1. Prevention of Scarring of Lung Parenchyma in COVID-19 Patients through Glucocorticoid Treatment.
Bozkurt N; Yalcin AN
Am J Health Behav; 2023 Feb; 47(1):182-193. PubMed ID: 36945083
[No Abstract] [Full Text] [Related]
2. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
5. New Insights on Effects of Glucocorticoids in Patients With SARS-CoV-2 Infection.
Shacham EC; Ishay A
Endocr Pract; 2022 Oct; 28(10):1100-1106. PubMed ID: 35870803
[TBL] [Abstract][Full Text] [Related]
6. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
7. Radiologically Undetectable Latent Pulmonary Lymphocyte Infiltration Suggesting the Need for Early Glucocorticoid Therapy: An Autopsy Case of Rapidly Progressive COVID-19 Pneumonia with Lymphopenia.
Tanomogi N; Otani T; Araki J; Sugitani A; Itagaki S; Kiriu T; Shimada K
Intern Med; 2021 Jul; 60(13):2145-2148. PubMed ID: 33994439
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on glucocorticoid treatment for COVID-19: a systematic review.
Cordeiro LP; Linhares EONN; Nogueira FGO; Moreira-Silva D; Medeiros-Lima DJM
Pharmacol Rep; 2021 Jun; 73(3):728-735. PubMed ID: 33666864
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
10. Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study.
Pagnesi M; Inciardi RM; Lombardi CM; Agostoni P; Ameri P; Barbieri L; Bellasi A; Camporotondo R; Canale C; Carubelli V; Carugo S; Catagnano F; Dalla Vecchia LA; Danzi GB; Di Pasquale M; Gaudenzi M; Giovinazzo S; Gnecchi M; Guazzi M; Iorio A; La Rovere MT; Leonardi S; Maccagni G; Mapelli M; Margonato D; Merlo M; Monzo L; Mortara A; Nuzzi V; Piepoli M; Porto I; Pozzi A; Sarullo F; Sinagra G; Tedino C; Tomasoni D; Volterrani M; Zaccone G; Senni M; Metra M
Int J Infect Dis; 2021 Jul; 108():270-273. PubMed ID: 34052406
[TBL] [Abstract][Full Text] [Related]
11. Incidental Findings Suggestive of COVID-19 Pneumonia in Oncologic Patients Undergoing
Wakfie-Corieh CG; Ferrando-Castagnetto F; García AMB; García-Esquinas MG; Candil AO; Rey CR; Cabrera-Martín MN; Cano AD; Delgado JLC
J Nucl Med; 2022 Feb; 63(2):274-279. PubMed ID: 34088776
[TBL] [Abstract][Full Text] [Related]
12. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
He F; Luo Q; Lei M; Fan L; Shao X; Hu K; Qin S; Yu N; Cao J; Yang L
Clin Rheumatol; 2020 Sep; 39(9):2803-2810. PubMed ID: 32725351
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
[TBL] [Abstract][Full Text] [Related]
14. Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment.
Myall KJ; Mukherjee B; Castanheira AM; Lam JL; Benedetti G; Mak SM; Preston R; Thillai M; Dewar A; Molyneaux PL; West AG
Ann Am Thorac Soc; 2021 May; 18(5):799-806. PubMed ID: 33433263
[No Abstract] [Full Text] [Related]
15. Follow-Up Analysis of Pulmonary Function, Exercise Capacity, Radiological Changes, and Quality of Life Two Months after Recovery from SARS-CoV-2 Pneumonia.
Strumiliene E; Zeleckiene I; Bliudzius R; Samuilis A; Zvirblis T; Zablockiene B; Strumila A; Gruslys V; Malinauskiene L; Kasiulevicius V; Jancoriene L
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204878
[No Abstract] [Full Text] [Related]
16. Use of glucocorticoids and azithromycin in the therapy of COVID-19.
de Lemos Neto M; Alexandre RCV; Morra ROG; da Paz JAS; Barroso SPC; Resende AC; de Medeiros-Lima DJM; Alexandre PCB
Pharmacol Rep; 2021 Dec; 73(6):1513-1519. PubMed ID: 34085181
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial.
Zhang C; Li J; Wu Z; Wang H; Que C; Zhao H; Wang G
Trials; 2020 Jun; 21(1):495. PubMed ID: 32513299
[TBL] [Abstract][Full Text] [Related]
18. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.
Ling Y; Xu SB; Lin YX; Tian D; Zhu ZQ; Dai FH; Wu F; Song ZG; Huang W; Chen J; Hu BJ; Wang S; Mao EQ; Zhu L; Zhang WH; Lu HZ
Chin Med J (Engl); 2020 May; 133(9):1039-1043. PubMed ID: 32118639
[TBL] [Abstract][Full Text] [Related]
19. Atypical Unilateral SARS-CoV-2 Pneumonia in a Single Lung Re-Transplanted Patient: A Case Report.
Furstenberger M; Gallais F; Freudenberger S; Kessler R; Chenard MP; Renaud-Picard B
Transplant Proc; 2022; 54(6):1564-1568. PubMed ID: 35773083
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 CT Scan Lung Segmentation: How We Do It.
Negroni D; Zagaria D; Paladini A; Falaschi Z; Arcoraci A; Barini M; Carriero A
J Digit Imaging; 2022 Jun; 35(3):424-431. PubMed ID: 35091874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
